Russian Sputnik V COVID-19 vaccine accepted for emergency use in Indonesia
- Indonesia approves Russian-made coronavirus vaccine.
- A thorough medication review was performed.
- Indonesia has registered over 4,000,000 COVID-19 cases so far.
Indonesia’s National Agency for Drug and Food Control announced Wednesday that the Russian-made Sputnik-V coronavirus vaccine has been approved in the country for use in an emergency.
“The National Agency for Drugs and Food approved another coronavirus vaccine, Sputnik V, on Tuesday, August 24,” reads the statement published today on the country’s National Agency for Drugs and Food Control.
Agency chief Penny Lukito said a thorough review of the drugs had been carried out. She added that the effectiveness of Sputnik V is 91.6%.
In turn, the Russian Direct Investment Fund (RDIF) said Indonesia was the 70th country to approve Sputnik V. The total population of the countries that have approved the Russian vaccine is four billion, which is 50% of the world’s population.
“Indonesia is one of the most populous nations in Asia and the addition of Sputnik V to the national vaccine portfolio will enable the use of one of the safest and most effective vaccines in the world,” said the CEO of RDIF.
Indonesia has so far recorded over four million coronavirus cases, more than 128,000 deaths and approximately 3.6 million recoveries. The country’s authorities have previously approved the use of coronavirus vaccines from Sinovac, Sinopharm, AstraZeneca, Moderna and Pfizer.
